This test detects early kidney damage that standard creatinine and eGFR measurements can miss, and its particularly relevant because GLP-1 medications have demonstrated kidney-protective effects that are worth tracking from a solid baseline
Semaglutide versus dulaglutide once weekly in patients with Type 2 diabetes (SUSTAIN 7): A randomised, open-label, phase 3b trial, The Lancet Diabetes & Endocrinology (2018) Ozempic semaglutide injection, solution, DailyMed (2024) Trulicity dulaglutide injection, solution, DailyMed (2024) Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: a multidisciplinary expert consensus, Journal of Clinical Medicine (2022) Possible side effects of Ozempic (semaglutide) injection, Novo Nordisk An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg, Diabetes, Obesity and Metabolism (2021) SUSTAIN 7: Ozempic versus Trulicity, NovoMedlink Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
doi: 10.1080/21655979.2019.1657327
Quick weight loss, as with GLP-1 meds, can exacerbate these effects
That means it is absorbed more easily by the body and does not require dietary restrictions
membranaceus , budesonide, and terbutaline or with aerosolized budesonide and terbutaline alone
